BlackRock Investment Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.19M Buy
103,996
+11,401
+12% +$493K ﹤0.01% 1885
2016
Q3
$6.21M Buy
92,595
+1,091
+1% +$55.2K 0.01% 1332
2016
Q2
$2.73M Buy
91,504
+81,963
+859% +$2.56M ﹤0.01% 1872
2016
Q1
$280K Sell
9,541
-2,634
-22% -$119K ﹤0.01% 3091
2015
Q4
$955K Sell
12,175
-2,899
-19% -$228K ﹤0.01% 2632
2015
Q3
$1.14M Sell
15,074
-11,093
-42% -$1.05M ﹤0.01% 2511
2015
Q2
$3.06M Sell
26,167
-50,459
-66% -$9.14M ﹤0.01% 1892
2015
Q1
$18.1M Buy
76,626
+1,832
+2% +$392K 0.02% 613
2014
Q4
$14.2M Sell
74,794
-1,484
-2% -$329K 0.02% 725
2014
Q3
$18.2M Sell
76,278
-1,356
-2% -$278K 0.03% 567
2014
Q2
$5.12M Buy
77,634
+13,414
+21% +$954K 0.01% 1370
2014
Q1
$6.69M Buy
64,220
+3,364
+6% +$395K 0.01% 1173
2013
Q4
$6.3M Sell
60,856
-1,546
-2% -$90.7K 0.01% 1193
2013
Q3
$3.35M Buy
62,402
+4,164
+7% +$224K 0.01% 1571
2013
Q2
$2.58M Buy
+58,238
New +$2.05M ﹤0.01% 1672

Other funds holding PBYI